Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SANTINI, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.528
EU - Europa 527
AS - Asia 349
SA - Sud America 6
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.525
IT - Italia 204
CN - Cina 178
SG - Singapore 131
DE - Germania 74
GB - Regno Unito 57
IE - Irlanda 41
SE - Svezia 38
FI - Finlandia 25
RU - Federazione Russa 23
FR - Francia 14
UA - Ucraina 14
TR - Turchia 11
RO - Romania 10
IR - Iran 9
BE - Belgio 5
CI - Costa d'Avorio 5
IN - India 5
AT - Austria 4
ES - Italia 4
JP - Giappone 4
UZ - Uzbekistan 4
CA - Canada 3
NL - Olanda 3
BG - Bulgaria 2
BR - Brasile 2
CL - Cile 2
EC - Ecuador 2
LB - Libano 2
PL - Polonia 2
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
PT - Portogallo 1
TW - Taiwan 1
Totale 4.416
Salva come PNG Salva come JPEG
Città #
Fairfield 750
Ashburn 354
Woodbridge 346
Houston 285
Seattle 285
Wilmington 249
Cambridge 225
Chandler 217
Ann Arbor 116
Singapore 108
Medford 67
Altamura 59
Lawrence 42
Princeton 42
Dublin 41
Des Moines 39
Dearborn 33
Nanjing 32
San Diego 30
London 28
Ludwigshafen am Rhein 27
Palermo 26
Santa Clara 23
Beijing 21
Berlin 18
Nanchang 15
Phoenix 15
Shenyang 15
Helsinki 14
Changsha 13
San Paolo di Civitate 13
Boardman 12
Jinan 12
Hebei 11
New York 11
Izmir 10
Milan 9
Tianjin 9
Chicago 8
Rome 8
Tulsa 8
Hangzhou 7
Redwood City 7
Tehran 7
Abidjan 5
Brussels 5
Jiaxing 5
Lucera 5
Orange 5
Saint Petersburg 5
Turin 5
Forest City 4
Guangzhou 4
Jacksonville 4
Kitzingen 4
Mehlingen 4
Moscow 4
Ningbo 4
Zhengzhou 4
Amsterdam 3
Bremen 3
Los Angeles 3
Paris 3
Sandston 3
Casteltermini 2
Chiswick 2
Columbus 2
Gallarate 2
Guayaquil 2
Iesi 2
Kumar 2
Lanzhou 2
Munich 2
Prineville 2
Pune 2
Redmond 2
Samarate 2
Springfield 2
Taizhou 2
Tokyo 2
Toronto 2
Acton 1
Andover 1
Ariccia 1
Assemini 1
Azzano San Paolo 1
Binago 1
Björklinge 1
Borås 1
Bristol 1
Caivano 1
Charlotte 1
Chisinau 1
Cixi 1
Dallas 1
Edinburgh 1
Florence 1
Fort Worth 1
Frankfurt am Main 1
Fuzhou 1
Totale 3.802
Salva come PNG Salva come JPEG
Nome #
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 184
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 169
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 169
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 167
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 154
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 151
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis 151
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 147
Lack of Correlation between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: A Retrospective Study 147
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 146
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 145
Cetuximab in small bowel adenocarcinoma: A new friend 142
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 140
New molecular targets in bone metastases 139
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 127
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 123
Deregulation of dicer and mir-155 expression in liposarcoma 120
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 118
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 115
Hepatocellular carcinoma treatment over sorafenib: Epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 115
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 114
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 113
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 112
The dark side of the moon: The PI3K/PTEN/AKT pathway in colorectal carcinoma 111
Update on capecitabine alone and in combination regimens in colorectal cancer patients 111
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 110
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 108
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma 105
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 102
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 101
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 89
The use of same in chemotherapy-induced liver injury 77
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 72
Recent advances in desmoid tumor therapy 71
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment † 68
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 66
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 64
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 51
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens 41
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 41
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies 38
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 31
Totale 4.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020955 0 0 0 0 184 208 136 121 132 68 83 23
2020/2021670 49 30 65 69 44 27 52 57 53 99 68 57
2021/2022555 32 123 25 13 8 17 25 38 45 69 79 81
2022/2023691 64 173 14 51 62 96 29 64 77 6 37 18
2023/2024270 20 30 32 15 17 33 35 9 2 4 3 70
2024/2025197 14 85 46 47 5 0 0 0 0 0 0 0
Totale 4.665